Gain-of-function mutations of Shp2 that disrupt the auto-inhibition were reported in Noonan Syndrome (NS), LEOPARD syndrome (LS) and juvenile myelomonocytic leukemia, but Shp2 mutations occur at low frequency in solid tumors7. Here, PTPN11 is linked to Leigh syndrome.